指南与共识技术与安全

欧洲骨髓瘤网络关于多发性骨髓瘤诊断与监测工具的建议:何时使用何种工具

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when.
指南 / 共识 · Haematologica · 2018-08-31

欧洲骨髓瘤网络更新多发性骨髓瘤诊断与监测工具指南,强调诊断需骨科、放射科、核医学、放疗、血液科和肿瘤科等多学科协作,定义基于临床、生化、组织病理和影像学标志物,分子分析用于高危分层,微小残留病评估通过流式细胞术、分子技术和影像学方法提供长期预后信息,指导未来临床试验治疗决策。

要点

  • 多发性骨髓瘤诊断需多学科协作,定义基于临床、生化、组织病理和影像学标志物。
  • 分子分析对定义高危骨髓瘤至关重要,用于更新患者分层。
  • 微小残留病评估通过流式细胞术、分子技术和影像学方法提供长期预后信息。

核心结论

  • 欧洲骨髓瘤网络更新了诊断建议,以在诊断和随访中适当使用这些建议。

研究设计与样本

  • 欧洲骨髓瘤网络(European Myeloma Network)制定的指南更新,基于专家建议。

诊断标准与关键数值

  • 多发性骨髓瘤定义基于临床、生化、组织病理和影像学疾病标志物的存在。
  • 分子分析用于定义高危骨髓瘤并用于更新患者分层。

临床应用与阅片要点

  • 诊断和随访中需使用特定检测以获得正确诊断并精确表征疾病。
  • 这些检测也可用于预后目的并有助于骨髓瘤患者随访。
  • 微小残留病评估通过流式细胞术、分子技术和影像学方法提供额外预后信息。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The diagnosis of multiple myeloma can be challenging, even for experienced physicians, and requires close collaboration between numerous disciplines (orthopedics, radiology, nuclear medicine, radiation therapy, hematology and oncology) before the final diagnosis of myeloma is made. The definition of multiple myeloma is based on the presence of clinical, biochemical, histopathological, and radiological markers of disease. Specific tests are needed both at presentation and during follow-up in order to reach the correct diagnosis and characterize the disease precisely. These tests can also serve prognostic purposes and are useful for follow-up of myeloma patients. Molecular analyses remain pivotal for defining high-risk myeloma and are used in updated patient stratifications, while minimal residual disease assessment via flow cytometry, molecular techniques and radiological approaches provides additional prognostic information on patients' long-term outcome. This pivotal information will guide our future treatment decisions in forthcoming clinical trials. The European Myeloma Network group updated their guidelines on different diagnostic recommendations, which should be of value to enable appropriate use of the recommendations both at diagnosis and during follow-up.

来源:Haematologica,查看原文。版权归原作者所有。

引用

  1. Caers J, Garderet L, Kortüm KM, et al. European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when. Haematologica. 2018. PMID: 30171031. doi:10.3324/haematol.2018.189159

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。